Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke

Antibody formation; Follow-up; High doses; IncobotulinumtoxinA; Long-term treatment; Spasticity; Botulinum Toxins; Type A; Chronic Disease; Disability Evaluation; Female; Follow-Up Studies; Humans; Intracranial Hemorrhages; Intracranial Thrombosis; Lower Extremity; Male; Middle Aged; Muscle Spasticity; Muscle; Skeletal; Neuromuscular Agents; Non-Randomized Controlled Trials as Topic; Stroke; Time Factors; Treatment Outcome; Upper Extremity; Neurology; Neurology (clinical)